Daily as of 3 Nov 16:00 ET
- Price
- below both $15.75 vs 50 $17.65 / 200 $15.85
- Projection
- 💀Death cross estimated in 12 to 18 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 2 Dec 2025 · projected 24 bars out
CGEM | Cullinan TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$15.75
+$0.82 (+5.49%)
Cullinan Therapeutics (CGEM) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Dec 2025, but the two have been closing on each other and a death cross is projected within 20 bars. Price sits below the 50 and the 200 on the daily, above both on the weekly and between the two on the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $15.03 vs 50 $14.79 / 200 $12.74
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 10 Aug 2026 · projected 24 bars out · tested 2 bars
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $15.75 vs 50 $14.93 / 200 $17.79
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 13 Oct 2026 · projected 27 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 13 Oct 2026 | 💀Death | 4-hour | 27 bars out | Not tested |
| week of 10 Aug 2026 | 🟨Golden moderate | weekly | 24 bars out | 2 bar cross test |
| 2 Dec 2025 | 🟨Golden moderate | daily | 24 bars out | Not tested |
| 4 Nov 2025 | 🟨Golden | 4-hour | 30 bars out | 4 bar cross test |
| 11 Jul 2025 | 💀Death | 4-hour | 17 bars out | — |
About CGEM
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$14.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandsmall